These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. The adjuvant treatment of malignant melanoma. Reintgen D; Kirkwood J J Fla Med Assoc; 1997 Mar; 84(3):147-52. PubMed ID: 9143164 [TBL] [Abstract][Full Text] [Related]
28. Interferon for melanoma: another application of immunopharmacology. Nauman C JAMA; 1998 Apr 22-29; 279(16):1263. PubMed ID: 9565004 [No Abstract] [Full Text] [Related]
29. Sorting the hype from the facts in melanoma. Finkel E Lancet; 1998 Jun; 351(9119):1866. PubMed ID: 9652681 [No Abstract] [Full Text] [Related]
30. Inflammatory reaction presages response in melanoma skin lesions during i.m. rIFN alpha-2a-based treatment. Bracarda S; Roila F; Basurto C; Tonato M Ann Oncol; 1990 Sep; 1(5):381. PubMed ID: 2148107 [No Abstract] [Full Text] [Related]
31. Nursing management of patients with malignant melanoma receiving adjuvant alpha interferon-2b. Kiley KE; Gale DM Clin J Oncol Nurs; 1998 Jan; 2(1):11-6. PubMed ID: 9481251 [TBL] [Abstract][Full Text] [Related]
32. [Combination of interferon-alpha with cytostatic drugs: a potentially successful therapeutic approach in metastatic melanoma]. Garbe C; Zouboulis CC; Krüger S; Waibel M; Kreuser ED; Stadler R; Orfanos CE Hautarzt; 1992 Jan; 43(1):4-10. PubMed ID: 1369746 [TBL] [Abstract][Full Text] [Related]
33. [Development of interferon antibodies during the treatment of skin diseases with low-dose recombinant interferon alpha-2a]. Corbillet V; Celerier P; Lebon P; Litoux P; Dreno B Ann Med Interne (Paris); 1995; 146(6):399-403. PubMed ID: 8597337 [TBL] [Abstract][Full Text] [Related]
34. Economic analyses of benefit from interferon-alpha 2B in high-risk melanoma: trade-offs between completeness, simplicity and clarity. Hillner BE; Kirkwood JM Eur J Cancer; 1997 Aug; 33(9):1345-6. PubMed ID: 9337671 [No Abstract] [Full Text] [Related]
39. Malignant melanoma and adjuvant alpha interferon-2b for patients at high risk of relapse. Gale DM; Kiley KE Clin J Oncol Nurs; 1998 Jan; 2(1):5-10. PubMed ID: 9481250 [TBL] [Abstract][Full Text] [Related]
40. Combined interferon-alpha and interleukin-2 as adjuvant treatment for melanoma. Dummer R; Hauschild A; Henseler T; Burg G Lancet; 1998 Sep; 352(9131):908-9. PubMed ID: 9743016 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]